Standard BioTools Inc
NASDAQ:LAB
Standard BioTools Inc
Cash from Investing Activities
Standard BioTools Inc
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Standard BioTools Inc
NASDAQ:LAB
|
Cash from Investing Activities
$20.2m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Investing Activities
-$5.1B
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-35%
|
|
Danaher Corp
NYSE:DHR
|
Cash from Investing Activities
-$7.1B
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-18%
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Cash from Investing Activities
-$377.2m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-11%
|
|
Agilent Technologies Inc
NYSE:A
|
Cash from Investing Activities
-$301m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
20%
|
CAGR 10-Years
-3%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Investing Activities
-$1.6B
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-21%
|
See Also
What is Standard BioTools Inc's Cash from Investing Activities?
Cash from Investing Activities
20.2m
USD
Based on the financial report for Dec 31, 2023, Standard BioTools Inc's Cash from Investing Activities amounts to 20.2m USD.
What is Standard BioTools Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
34%
The average annual Cash from Investing Activities growth rates for Standard BioTools Inc have been -20% over the past three years , 34% over the past five years .